Histosonics, Inc.
HistoSonics is a venture-backed medical device start-up company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy. Histotripsy utilizes the pressure created by focused sound energy to liquify and destroy targeted tissue, including diseased tissue and tumors, at sub-cellular levels.
Seedtable Score
43
Startups
6
Funding Rounds
$468.1m
Money raised
Overview
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Histosonics, Inc. has raised a total of $414.13m in funding over 6 rounds.
Key Insights:
- HistoSonics October 2025 Venture Funding Round: $250m
- HistoSonics August 2024 Series D Funding round: $102m
- HistoSonics , June 2020: $40m
- HistoSonics Series B round: $11.13m
- HistoSonics Series A round: $11m
- HistoSonics funding round, April 2019: $54m